Previous Article | Next Article 
Infection and Immunity, February 2006, p. 904-909, Vol. 74, No. 2
0019-9567/06/$08.00+0 doi:10.1128/IAI.74.2.904-909.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Entamoeba histolytica Infection in Children and Protection from Subsequent Amebiasis
Rashidul Haque,1
Dinesh Mondal,1
Priya Duggal,2
Mamun Kabir,1
Shantanu Roy,1
Barry M. Farr,3
R. Bradley Sack,4 and
William A. Petri Jr.3*
International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh,1
Inherited Disease Research Branch, National Human Genome Research Institute, NIH, Baltimore, Maryland,2
University of Virginia, Charlottesville, Virginia,3
Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland4
Received 20 September 2005/
Returned for modification 20 October 2005/
Accepted 4 November 2005
The contribution of amebiasis to the burden of diarrheal disease in children and the degree to which immunity is acquired from natural infection were assessed in a 4-year prospective observational study of 289 preschool children in an urban slum in Dhaka, Bangladesh. Entamoeba histolytica infection was detected at least once in 80%, and repeat infection in 53%, of the children who completed 4 years of observation. Annually there were 0.09 episodes/child of E. histolytica-associated diarrhea and 0.03 episodes/child of E. histolytica-associated dysentery. Fecal immunoglobulin A (IgA) anti-parasite Gal/GalNAc lectin carbohydrate recognition domain (anti-CRD) was detected in 91% (183/202) of the children at least once and was associated with a lower incidence of infection and disease. We concluded that amebiasis was a substantial burden on the overall health of the cohort children. Protection from amebiasis was associated with a stool anti-CRD IgA response. The challenge of producing an effective vaccine will be to improve upon naturally acquired immunity, which does not provide absolute protection from reinfection.
* Corresponding author. Mailing address: Division of Infectious Diseases and International Health, University of Virginia Health System, Room 2115, MR4 Building, P.O. Box 801340, Charlottesville, VA 22908-1340. Phone: (434) 924-5621. Fax: (434) 924-0075. E-mail:
wap3g{at}virginia.edu.
Editor: J. F. Urban, Jr.
Infection and Immunity, February 2006, p. 904-909, Vol. 74, No. 2
0019-9567/06/$08.00+0 doi:10.1128/IAI.74.2.904-909.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Guo, X., Barroso, L., Becker, S. M., Lyerly, D. M., Vedvick, T. S., Reed, S. G., Petri, W. A. Jr., Houpt, E. R.
(2009). Protection against Intestinal Amebiasis by a Recombinant Vaccine Is Transferable by T Cells and Mediated by Gamma Interferon. Infect. Immun.
77: 3909-3918
[Abstract]
[Full Text]
-
Mondal, D., Haque, R., Sack, R. B., Kirkpatrick, B. D., Petri, W. A. Jr
(2009). Attribution of Malnutrition to Cause-Specific Diarrheal Illness: Evidence from a Prospective Study of Preschool Children in Mirpur, Dhaka, Bangladesh. Am J Trop Med Hyg
80: 824-826
[Abstract]
[Full Text]
-
Tachibana, H., Cheng, X.-J., Tsukamoto, H., Itoh, J.
(2009). Characterization of Entamoeba histolytica Intermediate Subunit Lectin-Specific Human Monoclonal Antibodies Generated in Transgenic Mice Expressing Human Immunoglobulin Loci. Infect. Immun.
77: 549-556
[Abstract]
[Full Text]
-
Ivory, C. P. A., Prystajecky, M., Jobin, C., Chadee, K.
(2008). Toll-Like Receptor 9-Dependent Macrophage Activation by Entamoeba histolytica DNA. Infect. Immun.
76: 289-297
[Abstract]
[Full Text]
-
Ivory, C. P. A., Chadee, K.
(2007). Intranasal Immunization with Gal-Inhibitable Lectin plus an Adjuvant of CpG Oligodeoxynucleotides Protects against Entamoeba histolytica Challenge. Infect. Immun.
75: 4917-4922
[Abstract]
[Full Text]
-
Melendez-Lopez, S. G., Herdman, S., Hirata, K., Choi, M.-H., Choe, Y., Craik, C., Caffrey, C. R., Hansell, E., Chavez-Munguia, B., Chen, Y. T., Roush, W. R., McKerrow, J., Eckmann, L., Guo, J., Stanley, S. L. Jr., Reed, S. L.
(2007). Use of Recombinant Entamoeba histolytica Cysteine Proteinase 1 To Identify a Potent Inhibitor of Amebic Invasion in a Human Colonic Model. Eukaryot Cell
6: 1130-1136
[Abstract]
[Full Text]
-
Ali, I. K. M., Mondal, U., Roy, S., Haque, R., Petri, W. A. Jr., Clark, C. G.
(2007). Evidence for a Link between Parasite Genotype and Outcome of Infection with Entamoeba histolytica. J. Clin. Microbiol.
45: 285-289
[Abstract]
[Full Text]
-
HAQUE, R., MONDAL, D., SHU, J., ROY, S., KABIR, M., DAVIS, A. N., DUGGAL, P., PETRI, W. A. JR
(2007). CORRELATION OF INTERFERON-{gamma} PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLS WITH CHILDHOOD MALNUTRITION AND SUSCEPTIBILITY TO AMEBIASIS. Am J Trop Med Hyg
76: 340-344
[Abstract]
[Full Text]
-
Leo, M., Haque, R., Kabir, M., Roy, S., Lahlou, R. M., Mondal, D., Tannich, E., Petri, W. A. Jr.
(2006). Evaluation of Entamoeba histolytica Antigen and Antibody Point-of-Care Tests for the Rapid Diagnosis of Amebiasis. J. Clin. Microbiol.
44: 4569-4571
[Abstract]
[Full Text]